[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:waldenstrom-macroglobulinemia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":242,"states":243},"Waldenstrom Macroglobulinemia",38,33,[8,16,22,28,34,40,47,54,60,66,72,78,84,91,97,103,109,115,121,128,134,140,146,152,158,163,169,175,181,187,192,198,204,210,217,223,229,236],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06986174","A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia",[12],"Phase 2","RECRUITING","2026-08-26T02:16:32.589113Z","2026-05-05T02:43:29.193878Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07231952","A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)\u002FLymphoplasmacytic Lymphoma (LPL)",[12],"2026-08-26T02:18:35.425468Z","2026-05-05T02:43:29.135309Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT04840602","Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia\u002FLymphoplasmacytic Lymphoma",[12],"2026-08-26T02:15:53.461103Z","2026-05-05T02:43:29.075935Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT06561347","Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM",[12],"2026-08-26T02:15:21.365312Z","2026-05-05T02:43:27.489259Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT06510491","Epcoritamab in Previously Treated WM",[12],"2026-08-26T02:18:58.141497Z","2026-05-05T02:35:31.605275Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":45,"content_modified":46},"NCT05006716","A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies",[44],"Phase 1\u002FPhase 2","2026-08-26T02:17:24.721169Z","2026-07-05T05:32:16.799692Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT07101328","A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )",[51],"Phase 1","2026-08-26T02:15:54.846520Z","2026-07-05T05:32:16.733199Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT04545762","Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma",[51],"2026-08-26T02:18:03.638950Z","2026-07-05T03:45:20.448716Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06712810","Q702 for the Treatment of Patients With Hematologic Malignancies",[51],"2026-08-26T02:16:20.336282Z","2026-05-05T02:43:29.581486Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT06708897","A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas",[51],"2026-08-26T02:17:57.117858Z","2026-05-05T02:43:29.367440Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT04830137","A Study of NX-2127 in Adults With Relapsed\u002FRefractory B-cell Malignancies",[51],"2026-08-26T02:17:33.002248Z","2026-05-05T02:43:29.192735Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05544019","Study of SGR-1505 in Mature B-Cell Neoplasms",[51],"2026-08-26T02:15:49.658025Z","2026-05-05T02:43:28.973931Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":89,"content_modified":90},"NCT01804686","A Long-term Extension Study of PCI-32765 (Ibrutinib)",[88],"Phase 3","2026-08-26T02:17:12.307088Z","2026-05-05T02:43:28.838066Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT06590961","UBX-303061 in Subjects With Relapsed\u002FRefractory B-Cell Malignancies",[51],"2026-08-26T02:16:15.345907Z","2026-05-05T02:43:28.529005Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT06667687","Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma",[51],"2026-08-03T03:43:00.111924Z","2026-05-05T02:43:28.358180Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT04728893","Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)",[12],"2026-08-26T02:17:42.501124Z","2026-05-05T02:43:28.133797Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT04775745","Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.",[51],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:27.754680Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT07424833","A Study of APG-3288 in Relapsed\u002FRefractory Blood Cancers",[51],"2026-08-26T02:16:34.792807Z","2026-05-05T02:43:27.286009Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":126,"content_modified":127},"NCT03537482","APG-2575 Study of Safety, Tolerability ,PK\u002FPD in Patients With Hematologic Malignancies",[125],"Early Phase 1","2026-08-26T02:16:45.157238Z","2026-05-05T02:43:27.097841Z",{"nct_id":129,"title":130,"phases":131,"status":13,"updated_at":132,"content_modified":133},"NCT05131022","A Study of NX-5948 in Adults With Relapsed\u002FRefractory B-cell Malignancies",[51],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:26.916657Z",{"nct_id":135,"title":136,"phases":137,"status":13,"updated_at":138,"content_modified":139},"NCT05780034","A Study of AC676 for the Treatment of Relapsed\u002FRefractory B-Cell Malignancies",[51],"2026-08-26T02:18:48.678868Z","2026-05-05T02:43:26.739406Z",{"nct_id":141,"title":142,"phases":143,"status":13,"updated_at":144,"content_modified":145},"NCT05602363","AS-1763 in Patients With Previously Treated CLL\u002FSLL or Non-Hodgkin Lymphoma",[51],"2026-08-26T02:17:36.611194Z","2026-05-05T02:35:31.742591Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT05640102","Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia",[],"2026-08-26T02:16:54.876240Z","2026-05-13T02:55:06.366994Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":156,"content_modified":157},"NCT05724121","Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax",[],"2026-08-26T02:17:05.997056Z","2026-05-13T02:55:06.373403Z",{"nct_id":159,"title":160,"phases":161,"status":13,"updated_at":107,"content_modified":162},"NCT00923507","Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia\u002FSmall Lymphocytic Lymphoma (CLL\u002FSLL), Lymphoplasmacytic Lymphoma (LPL)\u002FWaldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)",[],"2026-05-13T02:55:06.065687Z",{"nct_id":164,"title":165,"phases":166,"status":13,"updated_at":167,"content_modified":168},"NCT06151730","Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study",[],"2026-08-26T02:15:10.362237Z","2026-05-13T02:55:06.420129Z",{"nct_id":170,"title":171,"phases":172,"status":13,"updated_at":173,"content_modified":174},"NCT05556928","Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry",[],"2026-08-26T02:15:00.557154Z","2026-05-13T02:55:06.362539Z",{"nct_id":176,"title":177,"phases":178,"status":13,"updated_at":179,"content_modified":180},"NCT02269592","Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome",[],"2026-08-26T02:17:58.890423Z","2026-05-13T02:55:06.091298Z",{"nct_id":182,"title":183,"phases":184,"status":13,"updated_at":185,"content_modified":186},"NCT01137643","Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer",[],"2026-08-26T02:16:58.658552Z","2026-05-13T02:55:06.068895Z",{"nct_id":188,"title":189,"phases":190,"status":13,"updated_at":113,"content_modified":191},"NCT05643235","Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors",[],"2026-05-05T02:35:31.579917Z",{"nct_id":193,"title":194,"phases":195,"status":13,"updated_at":196,"content_modified":197},"NCT03557619","A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies",[51],"2026-08-26T02:15:03.757872Z","2026-05-05T02:43:28.854165Z",{"nct_id":199,"title":200,"phases":201,"status":13,"updated_at":82,"content_modified":203},"NCT05170399","Vaccine Responses in Patients With B Cell Malignancies",[202],"Phase 4","2026-05-05T02:43:28.478955Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":208,"content_modified":209},"NCT06860880","Combating Cancer-Related Fatigue: A Personalized Supportive Care Program",[],"2026-08-26T02:16:57.705506Z","2026-05-05T02:43:28.349178Z",{"nct_id":211,"title":212,"phases":213,"status":214,"updated_at":215,"content_modified":216},"NCT07548450","Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)",[12],"NOT_YET_RECRUITING","2026-08-26T02:18:42.501841Z","2026-05-05T02:43:28.868643Z",{"nct_id":218,"title":219,"phases":220,"status":214,"updated_at":221,"content_modified":222},"NCT07420959","ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia",[44],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:27.426606Z",{"nct_id":224,"title":225,"phases":226,"status":214,"updated_at":227,"content_modified":228},"NCT07711327","Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy",[],"2026-08-26T02:15:39.267524Z","2026-07-19T19:36:05.092196Z",{"nct_id":230,"title":231,"phases":232,"status":233,"updated_at":234,"content_modified":235},"NCT05190705","Loncastuximab Tesirine in WM",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:32.170340Z","2026-05-05T02:43:28.287137Z",{"nct_id":237,"title":238,"phases":239,"status":233,"updated_at":240,"content_modified":241},"NCT05734495","Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia",[12],"2026-08-03T03:37:48.267540Z","2026-05-05T02:43:28.019151Z",[],[244,248,252,256,259,263,267,271,274,278,281,285,288,291,294,298,301,305,309,312,315,318,322,325],{"state":245,"count":246,"slug":247},"Texas",15,"texas",{"state":249,"count":250,"slug":251},"North Carolina",13,"north-carolina",{"state":253,"count":254,"slug":255},"California",12,"california",{"state":257,"count":254,"slug":258},"Massachusetts","massachusetts",{"state":260,"count":261,"slug":262},"Ohio",11,"ohio",{"state":264,"count":265,"slug":266},"New York",10,"new-york",{"state":268,"count":269,"slug":270},"Florida",9,"florida",{"state":272,"count":269,"slug":273},"Washington","washington",{"state":275,"count":276,"slug":277},"Michigan",8,"michigan",{"state":279,"count":276,"slug":280},"Minnesota","minnesota",{"state":282,"count":283,"slug":284},"Colorado",7,"colorado",{"state":286,"count":283,"slug":287},"Illinois","illinois",{"state":289,"count":283,"slug":290},"Maryland","maryland",{"state":292,"count":283,"slug":293},"New Jersey","new-jersey",{"state":295,"count":296,"slug":297},"Utah",6,"utah",{"state":299,"count":296,"slug":300},"Wisconsin","wisconsin",{"state":302,"count":303,"slug":304},"Oregon",5,"oregon",{"state":306,"count":307,"slug":308},"Arizona",4,"arizona",{"state":310,"count":307,"slug":311},"Kentucky","kentucky",{"state":313,"count":307,"slug":314},"Tennessee","tennessee",{"state":316,"count":307,"slug":317},"Virginia","virginia",{"state":319,"count":320,"slug":321},"Alabama",3,"alabama",{"state":323,"count":320,"slug":324},"Connecticut","connecticut",{"state":326,"count":320,"slug":327},"Georgia","georgia"]